Emergency treatment of asthma

New England Journal of Medicine

Volumn 363, Issue 8, 2010, Pages 755-764

  Lazarus, Stephen C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BITOLTEROL; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; HELIOX; IPRATROPIUM BROMIDE; LEVALBUTEROL; MAGNESIUM SULFATE; METHYLPREDNISOLONE; MONTELUKAST; PIRBUTEROL; PREDNISOLONE; PREDNISONE; SALBUTAMOL; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADRENAL SUPPRESSION; ADULT; AIRWAY OBSTRUCTION; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BLURRED VISION; CASE REPORT; CATARACT; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; COUGHING; CUSHING SYNDROME; DIABETES MELLITUS; DISEASE CONTROL; DISEASE DURATION; DISEASE EXACERBATION; DRUG MEGADOSE; DYSPNEA; EMERGENCY TREATMENT; FEMALE; FORCED EXPIRATORY VOLUME; GROWTH DISORDER; HEART PALPITATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOKALEMIA; INTENSIVE CARE UNIT; INTUBATION; METERED DOSE INHALER; MUSCLE WEAKNESS; PATIENT ASSESSMENT; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; SIDE EFFECT; TACHYCARDIA; TREATMENT DURATION; TREMOR; WEIGHT GAIN; WHEEZING; XEROSTOMIA; ASTHMATIC STATE; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; REVIEW;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHOLINERGIC ANTAGONISTS; EMERGENCY TREATMENT; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MIDDLE AGED; OXYGEN INHALATION THERAPY; PRACTICE GUIDELINES AS TOPIC; STATUS ASTHMATICUS;

EID: 77955912801     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1003469     Document Type: Article

References (52)

1. Rowe BH, Voaklander DC, Wang D, et al. Asthma presentations by adults to emergency departments in Alberta, Canada: a large population-based study. Chest 2009;135:57-65.
2. Moorman JE, Rudd RA, Johnson CA, et al. National surveillance for asthma - United States, 1980-2004. MMWR Surveill Summ 2007;56:1-54.
3. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma: full report 2007. (Accessed July 23, 2010, at http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.)
4. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006;2:CD000052.
5. Dhuper S, Chandra A, Ahmed A, et al. Efficacy and cost comparisons of bronchodilatator administration between metered dose inhalers with disposable spacers and nebulizers for acute asthma in an inner-city adult population. J Emerg Med 2008 December 10 (Epub ahead of print).
6. Rodrigo GJ, Rodrigo C. Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 2002;122:160-5. (Pubitemid 34754156)
7. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003;4:CD001115.
8. Carl JC, Myers TR, Kirchner HL, Kercsmar CM. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma. J Pediatr 2003;143:731-6.
9. Qureshi F, Zaritsky A, Welch C, Meadows T, Burke BL. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med 2005;46:29-36. (Pubitemid 40916893)
10. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000;161:1862-8.
11. Gelb AF, Karpel J, Wise RA, Cassino C, Johnson P, Conoscenti CS. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. Pulm Pharmacol Ther 2008;21:630-6. (Pubitemid 351970712)
12. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2000;4:CD000060.
13. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005;60:740-6. [Errata, Thorax 2008;63:1029, 2006;61:274, 458.]
14. Fanta CH, Rossing TH, McFadden ER Jr. Glucocorticoids in acute asthma: a critical controlled trial. Am J Med 1983;74:845-51.
15. Littenberg B, Gluck EH. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med 1986;314:150-2.
16. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. Chest 1999;116:285-95. (Pubitemid 29382109)
17. Rowe BH, Edmonds ML, Spooner CH, Diner B, Camargo CA Jr. Corticosteroid therapy for acute asthma. Respir Med 2004;98:275-84.
18. Krishnan JA, Davis SQ, Naureckas ET, Gibson P, Rowe BH. An umbrella review: corticosteroid therapy for adults with acute asthma. Am J Med 2009;122:977-91.
19. Harrison BD, Stokes TC, Hart GJ, Vaughan DA, Ali NJ, Robinson AA. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet 1986;1:181-4.
20. Ratto D, Alfaro C, Sipsey J, Glovsky MM, Sharma OP. Are intravenous corticosteroids required in status asthmaticus? JAMA 1988;260:527-9.
21. Jónsson S, Kjartansson G, Gíslason D, Helgason H. Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest 1988;94:723-6.
22. Engel T, Dirksen A, Frølund L, et al. Methylprednisolone pulse therapy in acute severe asthma: a randomized, double-blind study. Allergy 1990;45:224-30.
23. Bowler SD, Mitchell CA, Armstrong JG. Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax 1992;47:584-7.
24. Emerman CL, Cydulka RK. A randomized comparison of 100-mg vs 500-mg dose of methylprednisolone in the treatment of acute asthma. Chest 1995;107:1559-63.
25. Marquette CH, Stach B, Cardot E, et al. High-dose and low-dose systemic corticosteroids are equally efficient in acute severe asthma. Eur Respir J 1995;8:22-7. [Erratum, Eur Respir J 1995;8:1435.]
26. Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2003;3:CD002308.
27. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA 1999;281:2119-26. (Pubitemid 29264691)
28. Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000;4:CD002742.
29. Karpel JP, Aldrich TK, Prezant DJ, Guguchev K, Gaitan-Salas A, Pathiparti R. Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: how often should treatments be administered? Chest 1997;112:348-56.
30. Strauss L, Hejal R, Galan G, Dixon L, McFadden ER Jr. Observations on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 1997;155:454-8.
31. Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest 1998;113:593-8. (Pubitemid 28130929)
32. Rodrigo G, Rodrigo C. Early prediction of poor response in acute asthma patients in the emergency department. Chest 1998;114:1016-21. (Pubitemid 28495895)
33. Chey T, Jalaludin B, Hanson R, Leeder S. Validation of a predictive model for asthma admission in children: how accurate is it for predicting admissions? J Clin Epidemiol 1999;52:1157-63.
34. McCarren M, Zalenski RJ, McDermott M, Kaur K. Predicting recovery from acute asthma in an emergency diagnostic and treatment unit. Acad Emerg Med 2000;7:28-35.
35. Karras DJ, Sammon ME, Terregino CA, Lopez BL, Griswold SK, Arnold GK. Clinically meaningful changes in quantitative measures of asthma severity. Acad Emerg Med 2000;7:327-34.
36. Smith SR, Baty JD, Hodge D III. Validation of the pulmonary score: an asthma severity score for children. Acad Emerg Med 2002;9:99-104. (Pubitemid 34121590)
37. Gorelick MH, Stevens MW, Schultz TR, Scribano PV. Performance of a novel clinical score, the Pediatric Asthma Severity Score (PASS), in the evaluation of acute asthma. Acad Emerg Med 2004;11:10-8.
38. Kelly AM, Kerr D, Powell C. Is severity assessment after one hour of treatment better for predicting the need for admission in acute asthma? Respir Med 2004;98:777-81.
39. Darioli R, Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984;129:385-7.
40. Thill PJ, McGuire JK, Baden HP, Green TP, Checchia PA. Noninvasive positive-pressure ventilation in children with lower airway obstruction. Pediatr Crit Care Med 2004;5:337-42. [Erratum, Pediatr Crit Care Med 2004;5:590.]
41. Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003;123:1018-25. (Pubitemid 36444356)
42. Blais L, Ernst P, Boivin JF, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998;158:126-32.
43. Sin DD, Man SF. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med 2002;162:1591-5.
44. Jones LA, Goodacre S. Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments. Emerg Med J 2009;26:783-5.
45. Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Emerg Med J 2007;24:823-30. (Pubitemid 350200629)
46. Rowe BH, Camargo CA Jr. The role of magnesium sulfate in the acute and chronic management of asthma. Curr Opin Pulm Med 2008;14:70-6.
47. NIHR Health Technology Assessment Program. The 3Mg Trial: randomised controlled trial of intravenous or nebulised magnesium sulphate or standard therapy for acute severe asthma. 2010. (Accessed July 23, 2010, at http://www.hta.ac.uk/project/1619.asp.)
48. Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006;4:CD002884.
49. Liu MC, Dubé LM, Lancaster J. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. J Allergy Clin Immunol 1996;98:859-71. (Pubitemid 26405886)
50. Dockhorn RJ, Baumgartner RA, Leff JA, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000;55:260-5.
51. Camargo CA Jr, Gurner DM, Smithline HA, et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010;125:374-80.
52. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-78.